Capital Research reports 4.7% stake in Air Products
Air Products and Chemicals, Inc. — Schedule 13G/A amendment.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Air Products and Chemicals, Inc. — Schedule 13G/A amendment. Capital Research Global Investors reports beneficial ownership of 10,412,267 shares of common stock, representing 4.7% of the 222,656,008 shares believed to be outstanding. The filing shows sole voting power for 10,407,997 shares and sole dispositive power for 10,412,267 shares. The amendment is signed by a Capital Research officer on 05/11/2026.
Insights
Institution holds a sub-5% passive stake in APD, disclosed via Schedule 13G/A.
Capital Research Global Investors reports beneficial ownership of 10,412,267 shares (approximately 4.7%) of APD common stock. The filing lists sole voting power of 10,407,997 shares and sole dispositive power of 10,412,267.
As a Schedule 13G/A amendment, this is consistent with passive institutional disclosure rather than an active change in control. Subsequent filings would show any material changes in position; timing shown by the signature date is 05/11/2026.
Key Figures
Key Terms
Schedule 13G/A regulatory
beneficial ownership financial
sole dispositive power financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Capital Research Global Investors report in APD?
Is this Schedule 13G/A an active takeover signal for APD (ticker APD)?
What entity is filing on behalf of the holder in this APD filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.